# A Trial Investigating Lu AF82422 in Healthy Chinese and Caucasian Adults

> **NCT06258720** · PHASE1 · COMPLETED · sponsor: **H. Lundbeck A/S** · enrollment: 24 (actual)

## Conditions studied

- Healthy Participants

## Interventions

- **DRUG:** Lu AF82422

## Key facts

- **NCT ID:** NCT06258720
- **Lead sponsor:** H. Lundbeck A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2024-03-18
- **Primary completion:** 2024-09-03
- **Final completion:** 2024-09-03
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2024-11-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06258720

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06258720, "A Trial Investigating Lu AF82422 in Healthy Chinese and Caucasian Adults". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06258720. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*